Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study
Open Access
- 3 July 2013
- journal article
- Published by Brieflands in Hepatitis Monthly
- Vol. 13 (7) , e8351
Abstract
Background: Hepatocellular carcinoma is a highly progressive cancer in the case of late diagnosis which is frequently associated with HBV and HCV viral infections. Objectives: To identify differentially expressed serum proteins among three main stages of HCV infection and healthy individuals, and their comparisons with sera from patients with the same stage of HBV infection. Patients and Methods: Two-dimensional polyacrylamide gel electrophoresis combined with liquid chromatography-tandem mass spectrometry was performed on 47 sera from healthy volunteers, those with chronic active hepatitis, cirrhosis and HCC patients associated with HBV and HCV infections. Results: Among these, 62 spots were differentially expressed (≥ 1.5 fold; P < 0.05), of which 42 spots that corresponded to 15 proteins were identified by liquid chromatography-tandem mass spectrometry. CD5-like antigen (CD5L) was differentially expressed between cirrhosis and HCC patients with HCV infection. Leucine-rich α2-glycoprotein (LRG) and haptoglobin (HP) α2 isoforms differed in the HCC that was associated with either HCV or HBV infections. Conclusions: CD5L might be a useful biomarker for early diagnosis of HCC in HCV cirrhotic patients. LRG and HP α2 isoforms could be potential markers for distinguishing viral HCC. Our results also further support the presence of varying molecules involved in hepatocarcinogenesis in HBV when compared with HCV infection. Keywords: Cirrhosis; Hepatitis B Virus; Hepatitis C Virus; Hepatocellular CarcinomaKeywords
This publication has 39 references indexed in Scilit:
- Differential expression of haptoglobin isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV infectionOncology Letters, 2011
- Viral hepatocarcinogenesisOncogene, 2010
- Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in‐gel electrophoresisElectrophoresis, 2010
- A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver diseaseBMC Cancer, 2009
- Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkersExperimental & Molecular Medicine, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- A Role for Human SPα as a Pattern Recognition ReceptorJournal of Biological Chemistry, 2005
- Natural History and Prognosis of Hepatitis BSeminars in Liver Disease, 2003
- Pre-treatment levels of anti-HCV core IgM antibodies are closely associated with response to alpha interferon therapy in chronic hepatitis C patientsEuropean Journal of Gastroenterology & Hepatology, 1997
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosisJournal of Hepatology, 1994